Colgate-Palmolive (NYSE:CL) Position Reduced by Securian Asset Management Inc.

Securian Asset Management Inc. decreased its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,910 shares of the company’s stock after selling 1,281 shares during the period. Securian Asset Management Inc.’s holdings in Colgate-Palmolive were worth $3,992,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Swedbank AB raised its holdings in Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after purchasing an additional 40,324 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Colgate-Palmolive during the third quarter worth approximately $109,000. Apollon Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 3.9% in the third quarter. Apollon Wealth Management LLC now owns 22,571 shares of the company’s stock valued at $2,343,000 after buying an additional 839 shares in the last quarter. Harbour Investments Inc. increased its holdings in shares of Colgate-Palmolive by 7.1% in the third quarter. Harbour Investments Inc. now owns 9,836 shares of the company’s stock valued at $1,021,000 after buying an additional 650 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Colgate-Palmolive by 1.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,989,776 shares of the company’s stock valued at $206,559,000 after buying an additional 23,099 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 3.6 %

NYSE CL opened at $90.71 on Thursday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $73.61 billion, a PE ratio of 25.77, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The firm’s fifty day simple moving average is $89.03 and its 200-day simple moving average is $94.96.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $101.61.

Check Out Our Latest Stock Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.